CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 25,009	$ 29,922
Grant receivables	2,686	1,281
Prepaid expenses and other current assets	1,860	3,019
Total current assets	29,555	34,222
Property and equipment, net	181	284
Right-of-use assets, operating leases	498	657
Total assets	30,234	35,163
Current liabilities:
Accounts payable	1,984	3,695
Accrued expenses	7,620	4,055
Deferred grant income, current	1,066	1,701
Operating lease liabilities, current	193	174
Other current liabilities	279	544
Total current liabilities	11,142	10,169
Operating lease liabilities, non-current	342	520
Total liabilities	11,484	10,689
Commitments and contingencies (Note 7)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and December 31, 2023
Common stock, $0.001 par value, 250,000,000 shares authorized; 59,854,877 and 32,165,478 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	60	32
Additional paid-in capital	193,850	165,826
Accumulated deficit	(175,160)	(141,189)
Accumulated other comprehensive loss		(195)
Total stockholders' equity	18,750	24,474
Total liabilities and stockholders' equity	$ 30,234	$ 35,163

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).